MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
pmid:11237600 | ||||
Perera M et al. | The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study. | 2001 | J. Clin. Endocrinol. Metab. | pmid:11238498 |
Dören M et al. | Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. | 2001 | Fertil. Steril. | pmid:11239541 |
Garceau RJ et al. | Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other oral contraceptives. | 2000 | Contraception | pmid:11239615 |
Saha A et al. | Effects of oral contraceptive norethindrone on blood-lipid and lipid peroxidation parameters. | 2000 Nov-Dec | Acta Pol Pharm | pmid:11243250 |
Elomaa K et al. | The possible role of enterohepatic cycling on bioavailability of norethisterone and gestodene in women using combined oral contraceptives. | 2001 | Contraception | pmid:11257243 |
Boyd RA et al. | Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol. | 2001 | Contraception | pmid:11292470 |
pmid:11293581 | ||||
Cacciatore B et al. | Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women. | 2001 | Am. J. Obstet. Gynecol. | pmid:11303197 |
Pirroinen O and Rauramo L | Oral conception and uterine size-ultrasonic study. | 1975 | Am. J. Obstet. Gynecol. | pmid:1130457 |